Endo International Shares Climb on Earnings Beat
Shares of the specialty-healthcare firm climbed on better-than-expected profits for the second quarter.
Endo International (ENDP) - Get Report shares surged Tuesday after the specialty-healthcare firm booked better-than-expected second-quarter earnings. Profits came in at $0.86 a share, topping estimates by 16 percent. Sales of $921 million were roughly seven percent above forecasts. The company also announced the appointment of Joseph Ciaffoni -- a former senior vice president at Biogen (BIIB) - Get Report -- as president of its U.S. branded businesses. Shares of Endo are up 45 percent over the past three months.
Employees of TheStreet are restricted from owning individual securities.
